Protara Therapeutics

Contributing Author

Recent Articles by Protara Therapeutics

Nov-10	Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
Nov-04	Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace TARA GlobeNewswire
Oct-01	Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Sep-02	Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Aug-27	Protara Therapeutics to Participate in Upcoming Investor Conferences TARA GlobeNewswire
Aug-11	Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
Aug-01	Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Jul-01	Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire
Jun-30	Protara Therapeutics Announces Addition to the Russell 3000 Index TARA GlobeNewswire
Jun-02	Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer TARA GlobeNewswire
May-13	Protara Therapeutics to Participate in Upcoming Investor Conferences TARA GlobeNewswire
May-08	Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update TARA GlobeNewswire
May-01	Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TARA GlobeNewswire